Techfields

For profitWebsite ↗

Also known as: Jiangsu XinChen-Techfields Pharma Co., LTD. | lead institution | Techfields Inc | Techfields Pharma Co. Ltd | Tianjin XinChen-Techfields Pharma Co., LTD.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2014

Last known activity

May 10, 2022

Timeline

2000s

Jun 1, 2004
Techfields— Founded

Drugs by trial phase (4 distinct, 8 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

tf0023

Indications

Studied for

Recent trials (12)

NCT05212818Study chairPhase 2May 10, 2022
NCT05212818Lead sponsorPhase 2May 10, 2022
NCT05324163Lead sponsorPhase 3Sep 29, 2021
NCT03691818Overall official - principal investigatorPhase 2Sep 28, 2018
NCT03691818Lead sponsorPhase 2Sep 28, 2018
NCT03110523Lead sponsorPhase 3Jul 10, 2017
NCT03081806Lead sponsorPhase 3Jun 30, 2017
NCT02785120Lead sponsorPhase 2Sep 1, 2016
NCT02785120Study chairPhase 2Sep 1, 2016
NCT02794740Lead sponsorPhase 1Jun 1, 2016
NCT02067611Sponsor investigatorPhase 2Feb 1, 2014
NCT02067611Study chairPhase 2Feb 1, 2014

Details

Founded: Suzhou, CN Jun 1, 2004
Last known activity: May 10, 2022